We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.3%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.5B
AUM Growth
+$36.7M
(+2.5%)
Cap. Flow
+$13M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
35.09%
Holding
241
New
19
Increased
69
Reduced
116
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$12.7M |
| 2 |
T-Mobile US
TMUS
|
+$7.22M |
| 3 |
Interface
TILE
|
+$3.79M |
| 4 |
Sysco
SYY
|
+$3.41M |
| 5 |
Boston Properties
BXP
|
+$3.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$10.1M |
| 2 |
Tesla
TSLA
|
+$5.18M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$4.83M |
| 4 |
Novartis
NVS
|
+$2.93M |
| 5 |
PayPal
PYPL
|
+$2.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.22% |
| 2 | Technology | 18.98% |
| 3 | Industrials | 13.44% |
| 4 | Communication Services | 11.84% |
| 5 | Consumer Discretionary | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Equinox Gold
EQX
$13.5B
| $80K | 0.01% |
+10,063
| New | +$93K |
|
227
Corbus Pharmaceuticals
CRBP
$189M
| $39K | ﹤0.01% |
667
| – | – |
|
|
CWBR
228
DELISTED
CohBar, Inc. Common Stock
CWBR
| $14K | ﹤0.01% |
+335
| New | +$15.9K |
|
229
Akamai
AKAM
$17.6B
| – | – |
-4,582
| Closed | -$481K |
|
230
Brookfield
BN
$110B
| – | – |
-10,004
| Closed | -$221K |
|
231
Chubb
CB
$132B
| – | – |
-1,372
| Closed | -$211K |
|
232
Chevron
CVX
$386B
| – | – |
-8,895
| Closed | -$751K |
|
233
Eversource Energy
ES
$26.9B
| – | – |
-2,342
| Closed | -$203K |
|
234
Factset
FDS
$9.89B
| – | – |
-638
| Closed | -$212K |
|
235
Golub Capital BDC
GBDC
$3.4B
| – | – |
-11,138
| Closed | -$157K |
|
236
FlexShares International Quality Dividend Index Fund
IQDF
$1.18B
| – | – |
-12,772
| Closed | -$309K |
|
237
Korro Bio
KRRO
$197M
| – | – |
-284
| Closed | -$501K |
|
238
Rollins
ROL
$17.6B
| – | – |
-8,197
| Closed | -$320K |
|
239
Sunrun
RUN
$2.37B
| – | – |
-3,171
| Closed | -$220K |
|
|
BKI
240
DELISTED
Black Knight, Inc. Common Stock
BKI
| – | – |
-2,600
| Closed | -$230K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Reynders McVeigh Capital Management held 241 positions worth $1.5B, up 2.5% from $1.46B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Reynders McVeigh Capital Management's Q1 2021 filing shows 19 new, 69 increased, 116 reduced and 12 closed positions. Its largest new stake was Interface: 319,195 shares worth $3.98M. The largest sale was Xilinx Inc, an estimated $10.1M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q1 2021 buy was Interface: 319,195 shares worth $3.98M.
- Reynders McVeigh Capital Management added most to Medtronic in Q1 2021, an estimated $12.7M increase.
- Reynders McVeigh Capital Management's biggest Q1 2021 reduction was Xilinx Inc, cutting an estimated $10.1M.
- Reynders McVeigh Capital Management fully exited Chevron in Q1 2021, selling an estimated $751K.
- Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $1.5B portfolio in Q1 2021.
- Reynders McVeigh Capital Management opened 19 new positions and closed 12 in Q1 2021.
- Reynders McVeigh Capital Management's portfolio value rose 2.5% quarter-over-quarter to $1.5B.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2021, filed 7 May 2021.